TY - JOUR
T1 - Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system
T2 - A mixed methods approach
AU - Devine, Emily Beth
AU - Lee, Chia Ju
AU - Overby, Casey L.
AU - Abernethy, Neil
AU - McCune, Jeannine
AU - Smith, Joe W.
AU - Tarczy-Hornoch, Peter
N1 - Funding Information:
This work was sponsored by AHRQ 5K08 HSO14739 (PI: Devine); NIH/NLM T15 LM07442 ; NIH/NHGRI T15 Hg000035 ; NIH NCCR UL1RR025014 (Overby).
PY - 2014/7
Y1 - 2014/7
N2 - Pharmacogenomics (PGx) is positioned to have a widespread impact on the practice of medicine, yet physician acceptance is low. The presentation of context-specific PGx information, in the form of clinical decision support (CDS) alerts embedded in a computerized provider order entry (CPOE) system, can aid uptake. Usability evaluations can inform optimal design, which, in turn, can spur adoption. Objectives: The study objectives were to: (1) evaluate an early prototype, commercial CPOE system with PGx-CDS alerts in a simulated environment, (2) identify potential improvements to the system user interface, and (3) understand the contexts under which PGx knowledge embedded in an electronic health record is useful to prescribers. Methods: Using a mixed methods approach, we presented seven cardiologists and three oncologists with five hypothetical clinical case scenarios. Each scenario featured a drug for which a gene encoding drug metabolizing enzyme required consideration of dosage adjustment. We used Morae® to capture comments and on-screen movements as participants prescribed each drug. In addition to PGx-CDS alerts, 'Infobutton®' and 'Evidence' icons provided participants with clinical knowledge resources to aid decision-making. Results: Nine themes emerged. Five suggested minor improvements to the CPOE user interface; two suggested presenting PGx information through PGx-CDS alerts using an 'Infobutton' or 'Evidence' icon. The remaining themes were strong recommendations to provide succinct, relevant guidelines and dosing recommendations of phenotypic information from credible and trustworthy sources; any more information was overwhelming. Participants' median rating of PGx-CDS system usability was 2 on a Likert scale ranging from 1 (strongly agree) to 7 (strongly disagree). Conclusions: Usability evaluation results suggest that participants considered PGx information important for improving prescribing decisions; and that they would incorporate PGx-CDS when information is presented in relevant and useful ways.
AB - Pharmacogenomics (PGx) is positioned to have a widespread impact on the practice of medicine, yet physician acceptance is low. The presentation of context-specific PGx information, in the form of clinical decision support (CDS) alerts embedded in a computerized provider order entry (CPOE) system, can aid uptake. Usability evaluations can inform optimal design, which, in turn, can spur adoption. Objectives: The study objectives were to: (1) evaluate an early prototype, commercial CPOE system with PGx-CDS alerts in a simulated environment, (2) identify potential improvements to the system user interface, and (3) understand the contexts under which PGx knowledge embedded in an electronic health record is useful to prescribers. Methods: Using a mixed methods approach, we presented seven cardiologists and three oncologists with five hypothetical clinical case scenarios. Each scenario featured a drug for which a gene encoding drug metabolizing enzyme required consideration of dosage adjustment. We used Morae® to capture comments and on-screen movements as participants prescribed each drug. In addition to PGx-CDS alerts, 'Infobutton®' and 'Evidence' icons provided participants with clinical knowledge resources to aid decision-making. Results: Nine themes emerged. Five suggested minor improvements to the CPOE user interface; two suggested presenting PGx information through PGx-CDS alerts using an 'Infobutton' or 'Evidence' icon. The remaining themes were strong recommendations to provide succinct, relevant guidelines and dosing recommendations of phenotypic information from credible and trustworthy sources; any more information was overwhelming. Participants' median rating of PGx-CDS system usability was 2 on a Likert scale ranging from 1 (strongly agree) to 7 (strongly disagree). Conclusions: Usability evaluation results suggest that participants considered PGx information important for improving prescribing decisions; and that they would incorporate PGx-CDS when information is presented in relevant and useful ways.
KW - Clinical decision support systems
KW - Clinical knowledge resources (not a MeSH term)
KW - Medical order entry systems
KW - Pharmacogenetics
KW - User-computer interface
UR - http://www.scopus.com/inward/record.url?scp=84902073932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902073932&partnerID=8YFLogxK
U2 - 10.1016/j.ijmedinf.2014.04.008
DO - 10.1016/j.ijmedinf.2014.04.008
M3 - Article
C2 - 24874987
AN - SCOPUS:84902073932
SN - 1386-5056
VL - 83
SP - 473
EP - 483
JO - International Journal of Medical Informatics
JF - International Journal of Medical Informatics
IS - 7
ER -